PMID: 7150472Aug 1, 1982

Syngeneic antitumour antibodies in rats: clearance of cell-bound antibody in vivo and in vitro

British Journal of Cancer
C J DeanJ M Styles


Hooded Lister/Cbi rats bearing the HSN.TC fibrosarcoma produced a high-titre non-complement-binding IgG antibody, and tests in vitro indicated that the syngeneic antibody was specific for this tumour. About 1.4 X 10(5) antibody molecules were bound per cell, a figure one eighth that for cells treated with a high-titre allo-antiserum. When tumour-bearer serum was passively transferred into congenitally athymic rats bearing the HSN.TC tumour the antibody was absorbed out specifically, by comparison with control animals or athymic rats bearing an unrelated tumour that was also syngeneic in Hooded rats. The kinetics of loss of antibody from the surface of HSN.TC cells has been monitored in vitro and the antibody has been found to have an extended half-life at the cell surface (greater than 40 h).


Sep 1, 1994·International Journal of Cancer. Journal International Du Cancer·O LégerC J Dean
Jan 1, 1990·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·M KitagawaT Kasuga

Related Concepts

Tumor Antibodies
Antibody Specificity
Tumor Antigens
Surface Antigens
Plasma Membrane
August Rats
Sarcoma, Jensen

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.